NCT01167699View on ClinicalTrials.gov

Oxycodone/Naloxone (OXN) Combination in Moderate to Severe Non-malignant Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

174

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
Pain
Interventions
DRUG

Oxycodone and naloxone

Oxycodone hydrochloride and naloxone hydrochloride combination, prolonged release

Trial Locations (1)

Unknown

Brussels

Sponsors
All Listed Sponsors
lead

Mundipharma Pharmaceuticals B.V.

INDUSTRY